Sidong Huang Selected Research

Sidong Huang Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 04/2009
4	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2018
4	Colonic Neoplasms (Colon Cancer) 04/2014 - 01/2012
3	Melanoma (Melanoma, Malignant) 11/2017 - 01/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 01/2019
2	Retinoblastoma (Glioblastoma, Retinal) 01/2019 - 10/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016 - 08/2015
2	Neuroblastoma 07/2010 - 04/2009
1	Triple Negative Breast Neoplasms 01/2022
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Small Cell Carcinoma 01/2019
1	Kidney Neoplasms (Kidney Cancer) 05/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2018
1	Carcinogenesis 11/2017
1	Chronic Pancreatitis 12/2016
1	Neoplasm Metastasis (Metastasis) 12/2016
1	Adenocarcinoma 08/2015
1	Stomach Neoplasms (Stomach Cancer) 04/2014
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2013
1	Lung Neoplasms (Lung Cancer) 11/2012

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2013
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2012
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2014 - 07/2010
4	Cyclin D1IBA 01/2020 - 01/2019
3	ChromatinIBA 01/2019 - 04/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2015
2	Small Interfering RNA (siRNA)IBA 01/2020 - 04/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2017 - 04/2014
2	Phosphotransferases (Kinase)IBA 04/2014 - 11/2012
2	ErbB Receptors (EGF Receptor)IBA 04/2014 - 11/2012
2	Gefitinib (Iressa)FDA Link 11/2012 - 01/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2010 - 04/2009
1	glembatumumab vedotinIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Buthionine SulfoximineIBA 01/2021
1	Phenformin (Fenformin)IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	CalciumIBA 01/2021
1	BiguanidesIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Epirubicin (Ellence)FDA LinkGeneric 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	adhesion receptorIBA 01/2020
1	LigandsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	CyclinsIBA 11/2019
1	Estrogen ReceptorsIBA 11/2019
1	Eukaryotic Initiation Factor-4A (Eukaryotic Initiation Factor 4A)IBA 11/2019
1	palbociclibIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2018
1	src-Family KinasesIBA 05/2018
1	Syk KinaseIBA 05/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 11/2017
1	Haloperidol (Haldol)FDA LinkGeneric 12/2016
1	Pimozide (Orap)FDA Link 12/2016
1	talazoparibIBA 08/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2015
1	DNA (Deoxyribonucleic Acid)IBA 08/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2014
1	Proto-Oncogene Proteins c-metIBA 04/2014
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2014
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 04/2014
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 04/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2014
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 11/2013
1	Mediator ComplexIBA 11/2012
1	Tyrosine (L-Tyrosine)FDA Link 11/2012
1	Oncogene Proteins (Oncogene Protein)IBA 01/2012
1	Cetuximab (Erbitux)FDA Link 01/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2012
1	VemurafenibIBA 01/2012
1	RetinoidsIBA 04/2009

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2012
3	Drug Therapy (Chemotherapy) 01/2021 - 11/2012
1	Investigational Therapies (Experimental Therapy) 01/2022